Sign in →

Test Code LAB4612 RESPIRATORY PANEL PCR

Important Note

Note: Ordering of this test is restricted. Please call Microbiology at 625-5828 for more information.

Infectious

Specimen Type

Nasopharyngeal swab in VTM

Turnaround Time

2 hours

Test Schedule

Daily

Sample Stability

Viral transport media:
Refrigerated: 3 days
Frozen: 1 year

Method

PCR

Synonyms

Respiratory Panel PCR

CPT Codes

0115U

Target Pathogens

Table 1: Targets Detected by the ePlex RP Panel

Target

Classification (Genome Type)

Seasonal Prevalence*

Most Commonly Infected Demographic

Adenovirus (A-F)

Adenovirus

(DNA)

Late Winter to early Summer

All ages, immunocompromised

Coronavirus

(229E, HKU1, NL63, OC43)

Coronavirus (RNA)

Winter, Spring

All ages

Human Metapneumovirus

Paramyxovirus

(RNA)

Winter

Children, elderly, immunocompromised

Human Rhinovirus/

Enterovirus

Picornavirus

(RNA)

Fall, Spring/Summer

All ages, immunocompromised

Influenza A

Orthomyxovirus

(RNA)

Winter

All ages

Influenza A H1

Influenza A H1-2009

Influenza A H3

Influenza B

Parainfluenza Virus 1

Paramyxovirus

(RNA)

Fall

All ages

Parainfluenza Virus 2

Fall, early Winter

Parainfluenza Virus 3

Spring, Summer

Parainfluenza Virus 4

Fall, early Winter

Respiratory Syncytial Virus A

Paramyxovirus

(RNA)

Winter

Infants, children, older adults

Respiratory Syncytial Virus B

Chlamydia pneumoniae

Bacterium

(DNA)

No peak season

All ages, most common in children

Mycoplasma pneumoniae

Bacterium

(DNA)

Late Summer, Fall

Children, young adults

*Based on northern hemisphere seasons

Limitations

This assay is not predicted to detect SARS-coronavirus (CoV), MERS-CoV, or the virus (SARS-CoV-2) causing coronavirus disease 2019 (COVID-19).

Purpose

The ePlex® Respiratory Pathogen (RP) Panel is a multiplexed nucleic acid in vitro diagnostic test intended for use on the ePlex Instrument for the simultaneous qualitative detection and identification of multiple respiratory viral and bacterial nucleic acids in nasopharyngeal swabs (NPS) obtained from individuals exhibiting signs and symptoms of respiratory tract infection.